Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes.
The DOI matches its Crossref record.
Abstract
BACKGROUND: Cardiac hypertrophy is commonly observed in acromegalic patients, in whom serum insulin-like growth factor-I (IGF-I) levels are elevated. In the present study, we examined whether IGF-I induces hypertrophy in cultured neonatal rat cardiomyocytes through its specific receptor and whether IGF binding protein-3 (IGFBP-3), which is a major circulating carrier protein for IGF-I, inhibits IGF-I-induced cardiac hypertrophy in vitro. METHODS AND RESULTS: Because the response of cardiac hypertrophy is characterized by the induction of expression for muscle-specific genes, the effect of IGF-I on steady-state levels of mRNA for myosin light chain-2 (MLC-2) and troponin I and for skeletal and cardiac alpha-actin isoforms was evaluated by Northern blot analysis. IGF-I (10(-7) M) increased mRNA levels for MLC-2 and troponin I as early as 60 minutes with maximum levels by 6 hours, which were maintained for as long as 24 hours. IGF-I (10(-7) M) also increased transcripts for skeletal alpha-actin but not for cardiac alpha-actin. The cell size as evaluated morphometrically was almost doubled after 48-hour treatment with IGF-I. IGF-I induction of protein synthesis was dose dependent (10(-10) to 10(-7) M) with a maximal 2.2-fold increase seen at 10(-8) M. In contrast to the hypertrophic effect of IGF-I, growth hormone affected neither protein synthesis nor expression for muscle-specific genes. Binding study using 125I-IGF-I revealed the presence of specific binding sites for IGF-I in rat cardiomyocytes. IGFBP-3 induced a dose-dependent inhibition of protein synthesis stimulated by IGF-I; IGFBP-3 (10(-7) M) completely inhibited the [3H]leucine uptake stimulated by IGF-I (10(-8) M). IGFBP-3 similarly inhibited the IGF-I-stimulated gene expressions for MLC-2 and troponin I. CONCLUSIONS: These results suggest that IGF-I directly causes cardiac hypertrophy and that its effect can be blocked by IGFBP-3.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Engineering Adolescence: Maturation of Human Pluripotent Stem Cell–Derived Cardiomyocytes
Yang, X., Pabon, L., & Murry, C. E. (2014) · Circulation Research · doi:10.1161/circresaha.114.300558 · Cited by 939
“IGF-1 treatment of NRVM leads to upregulation of myosine light chain-2 and troponinI, cell size doubling, with an increase in protein synthesis.(99) IGF-1 has also been reported(100) to influence the maturation of cardiomyocyte metabolism by enhancing the effect of the nuclear receptor/transcription factor peroxisome…”
BackgroundSignaling Pathways for Cardiac Hypertrophy and Failure
Hunter, J. J., & Chien, K. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910213411706 · Cited by 869
SACCÀ, L., CITTADINI, A., & FAZIO, S. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-5-555 · Cited by 543
McMullen, J. R., Shioi, T., Huang, W.-Y., Zhang, L., Tarnavski, O., Bisping, E., Schinke, M., Kong, S., Sherwood, M. C., Brown, J., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310405200 · Cited by 404
Cellular mechanisms of cardiac hypertrophy
Sugden, P. H., & Clerk, A. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050275 · Cited by 404
Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update
Gadelha, M. R., Kasuki, L., Lim, D. S. T., & Fleseriu, M. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00115 · Cited by 363
Kupfer, M. E., Lin, W.-H., Ravikumar, V., Qiu, K., Wang, L., Gao, L., Bhuiyan, D. B., Lenz, M., Ai, J., Mahutga, R. R., et al. (2020) · Circulation Research · doi:10.1161/circresaha.119.316155 · Cited by 329
Duerr, R. L., Huang, S., Miraliakbar, H. R., Clark, R., Chien, K. R., & Ross, J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117706 · Cited by 329
Verdecchia, P. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(03)01018-5 · Cited by 310
Ren, J., Samson, W. K., & Sowers, J. R. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1999.1036 · Cited by 304
Proliferation precedes differentiation in IGF-I-stimulated myogenesis.
Engert, J. C., Berglund, E. B., & Rosenthal, N. (1996) · The Journal of cell biology · doi:10.1083/jcb.135.2.431 · Cited by 296
Reiss, K., Cheng, W., Ferber, A., Kajstura, J., Li, P., Li, B., Olivetti, G., Homcy, C. J., Baserga, R., & Anversa, P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8630 · Cited by 292
Cittadini, A., Strömer, H., Katz, S. E., Clark, R., Moses, A. C., Morgan, J. P., & Douglas, P. S. (1996) · Circulation · doi:10.1161/01.cir.93.4.800 · Cited by 279
Fujisaki, H., Ito, H., Hirata, Y., Tanaka, M., Hata, M., Lin, M., Adachi, S., Akimoto, H., Marumo, F., & Hiroe, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118092 · Cited by 262
Self-citationVerdecchia, P., Reboldi, G., Schillaci, G., Borgioni, C., Ciucci, A., Telera, M. P., Santeusanio, F., Porcellati, C., & Brunetti, P. (1999) · Circulation · doi:10.1161/01.cir.100.17.1802 · Cited by 186
Beauchamp, P., Moritz, W., Kelm, J. M., Ullrich, N. D., Agarkova, I., Anson, B. D., Suter, T. M., & Zuppinger, C. (2015) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2014.0376 · Cited by 161
Impaired cardiac performance in GH-deficient adults and its improvement after GH replacement
Cittadini, A., Cuocolo, A., Merola, B., Fazio, S., Sabatini, D., Nicolai, E., Colao, A., Longobardi, S., Lombardi, G., & Sacca, L. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.267.2.e219 · Cited by 154
Hormonal profile in patients with congestive heart failure
Kontoleon, P. E., Anastasiou-Nana, M. I., Papapetrou, P. D., Alexopoulos, G., Ktenas, V., Rapti, A. C., Tsagalou, E. P., & Nanas, J. N. (2003) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00212-7 · Cited by 145
Echocardiographic Abnormalities in Normotensive Obese Patients: Relationship with Visceral Fat
Morricone, L., Malavazos, A. E., Coman, C., Donati, C., Hassan, T., & Caviezel, F. (2002) · Obesity Research · doi:10.1038/oby.2002.67 · Cited by 104
Fang, Y., Sun, W., Zhang, T., & Xiong, Z. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2021.121298 · Cited by 40
Doin, F. C., Rosa-Borges, M., Martins, M. R. A., Moisés, V. A., & Abucham, J. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0907 · Cited by 30
Metadata
- Authors
- Ito, H., Hiroe, M., Hirata, Y., Tsujino, M., Adachi, S., Shichiri, M., Koike, A., Nogami, A., & Marumo, F.
- Venue
- Circulation
- Published
- 1993-05
- Volume
- 87
- Issue
- 5
- Pages
- 1715-1721
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1984572394
- Cited by
- 408
- References
- 0
- FWCI
- 12.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.